GlaxoSmithKline Pharmaceuticals Ltd (500660) Stock Price & News

500660:BOM

GlaxoSmithKline Pharmaceuticals Ltd

₹2 531,90

-0,30%

(-7,50) 1D

15 Okt., 15:30:00 GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 500660...

Open

₹2 550,00

High

₹2 550,00

Low

₹2 489,60

Mkt. cap

428,59 mjd

Avg. vol.

5,03 k

Volume

4,20 k

Dividend

2,25%

Quarterly dividend

₹14,25

Ex-dividend date

29 Mei 2026

P/E ratio

40,15

52-wk high

₹3 121,10

52-wk low

₹2 088,00

EPS

₹63,05

Shares outstanding

169,41 m

No. of employees

3 k

Open

₹2 550,00

High

₹2 550,00

Low

₹2 489,60

Mkt. cap

428,59 mjd

Avg. vol.

5,03 k

Volume

4,20 k

Dividend

2,25%

Quarterly dividend

₹14,25

Ex-dividend date

29 Mei 2026

P/E ratio

40,15

52-wk high

₹3 121,10

52-wk low

₹2 088,00

EPS

₹63,05

Shares outstanding

169,41 m

No. of employees

3 k

Related stocks

500420

Torrent Pharmaceuticals Ltd

₹4 596,00

+0,04%

500124

Dr Reddy's Laboratories Ltd

Sun Pharmaceutical Industries Ltd

₹1 764,00

+1,01%

News stories

From web sources and news partners

Mining Weekly

47 minute gelede

Metal power producer Amaero announces $20m IPO on Nasdaq

Simply Wall Street

2 minute gelede

Analysts Expect Breakeven For Candel Therapeutics, Inc. (NASDAQ:CADL) Before Long

Stocktwits

1 uur gelede

Why Are Nasdaq Futures Sinking Premarket? CRWV, MU, TSM, SKHY, IBRX, RKLB, TSLA Stocks In Focus

Investor's Business Daily

7 uur gelede

Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?

Profile

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

About GlaxoSmithKline Pharmaceuticals Ltd

CEO-

Employees3,1 k

Founded13 Nov. 1924

Headquarters-

SectorPharmaceutical industry

Websiteindia-pharma.gsk.com

All values in INR	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	9,80 mjd	10,41 mjd	9,95 mjd	9,38 mjd
Cost of goods sold	3,56 mjd	3,64 mjd	3,69 mjd	3,28 mjd
Cost of revenue	3,56 mjd	3,64 mjd	3,69 mjd	3,28 mjd
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1,38 mjd	1,52 mjd	2,95 mjd	1,59 mjd
Operating expense	3,06 mjd	3,26 mjd	2,84 mjd	3,31 mjd
Total operating expenses	6,62 mjd	6,90 mjd	6,53 mjd	6,59 mjd
Operating income	3,18 mjd	3,51 mjd	3,43 mjd	2,80 mjd
Other non operating income	335,70 m	321,20 m	-1,09 mjd	437,60 m
EBT including unusual items	3,54 mjd	4,00 mjd	3,73 mjd	3,22 mjd
EBT excluding unusual items	3,51 mjd	3,82 mjd	2,94 mjd	3,22 mjd
Income tax expense	965,10 m	1,04 mjd	952,41 m	852,70 m
Effective tax rate	27,26%	26,08%	25,53%	26,44%
Other operating expenses	1,51 mjd	1,54 mjd	-236,82 m	1,56 mjd
Net income	2,57 mjd	2,96 mjd	2,78 mjd	2,37 mjd
Net profit margin	26,28%	28,39%	27,92%	25,27%
Earnings per share	-	-	-	14,00
Interest and investment income	-	-	657,30 m	-
Interest expense	-5,10 m	-11,90 m	-6,12 m	-9,70 m
Net interest expenses	-5,10 m	-11,90 m	651,18 m	-9,70 m
Depreciation and amortization charges	174,30 m	203,20 m	131,74 m	158,40 m
EBITDA	3,35 mjd	3,61 mjd	3,52 mjd	2,89 mjd
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything